1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Next generation sequencing (NGS) based IGH and TCR clonality assays provide excellent specificity and sensitivity for routine clonal characterization and monitoring of lymphoproliferative disorders
    Meeting Abstract

    Arcila, M. E.; Syed, M.; Yu, W.; Kim, H.; Yao, J.; Ho, C.; Petrova-Drus, K.; Roshal, M.; Park, J. H.; Landgren, O.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • The damage sensory molecule TRPA1 positively regulates endogenous thymic regeneration after damage
    Meeting Abstract

    Argyropoulos, K.; Velardi, E.; Tsai, J.; Lazrak, A.; Jahn, L.; Dudakov, J. A.; van den Brink, M. R. M.
    Blood (2017)

    Fulltext@MSK | Save
  • Impact of PET staging of follicular lymphoma on treatment outcomes and prognosis
    Meeting Abstract

    Alperovich, A.; Batlevi, C. L.; Intlekofer, A. M.; Moskowitz, C. H.; Horwitz, S. M.; Zelenetz, A. D.; Palomba, M. L.; Moskowitz, A. J.; Gerecitano, J.; Hamlin, P. A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Ivosidenib or enasidenib combined with standard induction chemotherapy is well tolerated and active in patients with newly diagnosed AML with an IDH1 or IDH2 mutation: Initial results from a phase 1 trial
    Meeting Abstract

    Stein, E. M.; DiNardo, C. D.; Mims, A. S.; Savona, M. R.; Pratz, K.; Stein, A. S.; Fathi, A. T.; Stone, R. M.; Pollyea, D. A.; Odenike, O.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • High durable CR rates in relapsed/refractory (R/R) aggressive B-NHL treated with the CD19-directed CAR T cell product JCAR017 (TRANSCEND NHL 001): Defined composition allows for dose-finding and definition of pivotal cohort
    Meeting Abstract

    Abramson, J. S.; Palomba, M. L.; Gordon, L. I.; Lunning, M. A.; Arnason, J. E.; Wang, M.; Forero, A.; Maloney, D. G.; Albertson, T.; Garcia, J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Ivosidenib (AG-120) in mutant IDH1 AML and advanced hematologic malignancies: Results of a phase 1 dose escalation and expansion study
    Meeting Abstract

    DiNardo, C. D.; De Botton, S.; Stein, E. M.; Roboz, G. J.; Mims, A. S.; Pollyea, D. A.; Swords, R. T.; Altman, J. K.; Collins, R. H.; Mannis, G. N.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • In vitro, in vivo, and parallel phase I evidence support the safety and activity of duvelisib, a PI3K-δ,γ inhibitor, in combination with romidepsin or bortezomib in relapsed/refractory T-cell lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Koch, R.; Mehta-Shah, N.; Myskowski, P.; Kheterpal, M.; Dogan, A.; Davey, T.; Galasso, N.; Evan, M.; Shah, M.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Utility of systemic staging in low grade B-cell lymphomas presenting in the skin
    Meeting Abstract

    Kheterpal, M.; Geller, S.; Dai, J.; Pulitzer, M.; Myskowski, P.; Moskowitz, A. J.; Kim, J.; Hoppe, R. T.; Kim, Y. H.; Horwitz, S. M.
    Blood (2017)

    Fulltext@MSK | Save
  • TET2 in normal and malignant hematopoiesis
    Journal Article

    Bowman, R. L.; Levine, R. L.
    Cold Spring Harbor Perspectives in Medicine (2017)

    Fulltext@MSK | Save
  • Quantitative analysis of T1-weighted MRI images as a surrogate for fat content does not correlate with response or survival
    Meeting Abstract

    Amer, A.; Gunjan, S.; Benjamin, D.; Sean, D.; Molly, M.; Yousef, M.; David, C.; Guenther, K.; Nikoletta, L.; Heather, L.; more...
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save